190 related articles for article (PubMed ID: 33570693)
1. Imaging of pediatric bone and growth disorders: Of diagnostic workhorses and new horizons.
Mehany SN; Patsch JM
Wien Med Wochenschr; 2021 Apr; 171(5-6):102-110. PubMed ID: 33570693
[TBL] [Abstract][Full Text] [Related]
2. Oral health-related quality of life in X-linked hypophosphataemia and osteogenesis imperfecta.
Gjørup H; Beck-Nielsen SS; Hald JD; Haubek D
J Oral Rehabil; 2021 Feb; 48(2):160-168. PubMed ID: 33058298
[TBL] [Abstract][Full Text] [Related]
3. Circulating sclerostin in children and young adults with heritable bone disorders.
Palomo T; Glorieux FH; Rauch F
J Clin Endocrinol Metab; 2014 May; 99(5):E920-5. PubMed ID: 24512494
[TBL] [Abstract][Full Text] [Related]
4. Transition of young adults with metabolic bone diseases to adult care.
Ross J; Bowden MR; Yu C; Diaz-Thomas A
Front Endocrinol (Lausanne); 2023; 14():1137976. PubMed ID: 37008909
[TBL] [Abstract][Full Text] [Related]
5. Health-related quality of life and a cost-utility simulation of adults in the UK with osteogenesis imperfecta, X-linked hypophosphatemia and fibrous dysplasia.
Forestier-Zhang L; Watts L; Turner A; Teare H; Kaye J; Barrett J; Cooper C; Eastell R; Wordsworth P; Javaid MK; Pinedo-Villanueva R
Orphanet J Rare Dis; 2016 Nov; 11(1):160. PubMed ID: 27894323
[TBL] [Abstract][Full Text] [Related]
6. The muscle-bone relationship in X-linked hypophosphatemic rickets.
Veilleux LN; Cheung MS; Glorieux FH; Rauch F
J Clin Endocrinol Metab; 2013 May; 98(5):E990-5. PubMed ID: 23526465
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis and management of pediatric metabolic bone diseases associated with skeletal fragility.
Charoenngam N; Cevik MB; Holick MF
Curr Opin Pediatr; 2020 Aug; 32(4):560-573. PubMed ID: 32692054
[TBL] [Abstract][Full Text] [Related]
8. [Evaluation of bone mineral density in selected regions of the skeleton in children with osteogenesis imperfecta and hypophosphatemic rickets].
Olszaniecka M; Lebiedowski M; Matusik H; Rowińska E; Wieczorek E; Lorenc R
Pol Tyg Lek; 1995 Nov; 50(44-47):32-4. PubMed ID: 8643422
[No Abstract] [Full Text] [Related]
9. Multidisciplinary patient care in X-linked hypophosphatemic rickets: one challenge, many perspectives.
Raimann A; Mindler GT; Kocijan R; Bekes K; Zwerina J; Haeusler G; Ganger R
Wien Med Wochenschr; 2020 Apr; 170(5-6):116-123. PubMed ID: 31993875
[TBL] [Abstract][Full Text] [Related]
10. [Type III osteogenesis imperfecta associated with hypophosphatemic vitamin D-resistant rickets].
Menzel D; Monnens L
Monatsschr Kinderheilkd; 1986 Oct; 134(10):755-7. PubMed ID: 3025669
[TBL] [Abstract][Full Text] [Related]
11. Changes in adipose bone marrow and bone morphology in X-linked hypophosphatemic rickets.
Nguyen-Khac V; Bonnet-Lebrun A; Skalli W; Adamsbaum C; Linglart A; Wicart P
Orthop Traumatol Surg Res; 2023 May; 109(3):103529. PubMed ID: 36565743
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of bone mineral density and microarchitectural parameters by DXA and HR-pQCT in 37 children and adults with X-linked hypophosphatemic rickets.
Colares Neto GP; Pereira RM; Alvarenga JC; Takayama L; Funari MF; Martin RM
Osteoporos Int; 2017 May; 28(5):1685-1692. PubMed ID: 28194480
[TBL] [Abstract][Full Text] [Related]
13. Muscle-Bone Interactions in Pediatric Bone Diseases.
Veilleux LN; Rauch F
Curr Osteoporos Rep; 2017 Oct; 15(5):425-432. PubMed ID: 28856575
[TBL] [Abstract][Full Text] [Related]
14. Material matters: a mechanostat-based perspective on bone development in osteogenesis imperfecta and hypophosphatemic rickets.
Rauch F
J Musculoskelet Neuronal Interact; 2006; 6(2):142-6. PubMed ID: 16849823
[TBL] [Abstract][Full Text] [Related]
15. [Diseases revealed by the mouth].
Opsahl-Vital S; Gaucher C; Bardet C; Courson F; Linglart A; Chaussain C
Arch Pediatr; 2015 May; 22(5 Suppl 1):151-2. PubMed ID: 26112566
[No Abstract] [Full Text] [Related]
16. [Rare bone disorders and respective treatments].
Seefried L; Jakob F
Internist (Berl); 2021 May; 62(5):486-495. PubMed ID: 33779789
[TBL] [Abstract][Full Text] [Related]
17. Lack of circulating pigment epithelium-derived factor is a marker of osteogenesis imperfecta type VI.
Rauch F; Husseini A; Roughley P; Glorieux FH; Moffatt P
J Clin Endocrinol Metab; 2012 Aug; 97(8):E1550-6. PubMed ID: 22669302
[TBL] [Abstract][Full Text] [Related]
18. Usefulness of X-rays in the Differential Diagnosis of Hypophosphataemic Rickets.
Martel-Villagrán J; Arias-Medina A; García-Mardones G
Adv Ther; 2020 May; 37(Suppl 2):89-94. PubMed ID: 32236877
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of FGFR Signaling Partially Rescues Hypophosphatemic Rickets in HMWFGF2 Tg Male Mice.
Xiao L; Du E; Homer-Bouthiette C; Hurley MM
Endocrinology; 2017 Oct; 158(10):3629-3646. PubMed ID: 28938491
[TBL] [Abstract][Full Text] [Related]
20. What every clinical geneticist should know about testing for osteogenesis imperfecta in suspected child abuse cases.
Pepin MG; Byers PH
Am J Med Genet C Semin Med Genet; 2015 Dec; 169(4):307-13. PubMed ID: 26566591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
